Addiction news and addiction widget

Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC) announced today encouraging results of a Phase I safety study investigating the potential interaction of EVT 302, a reversible and highly selective inhibitor of monoamine oxidase B (MAO-B) in development for smoking cessation, with tyramine. The study was undertaken to determine potential safety advantages of EVT 302 versus non-selective MAO inhibitors and less selective MAO-B inhibitors already on the market.

New research from the Department of health's Know Your Limits campaign reveals that the vast majority of UK women (82%) don't realise alcohol consumption can increase the risk of developing breast cancer. According to the General Household Survey, around 4 million women drink more than the NHS recommended daily limit of 2-3 units of alcohol, equivalent to one large glass of wine a day (250ml at ABV 12%).

Researchers at the University of Missouri suggest anti-tobacco campaigns should focus advertisements on either scaring their audience or disgusting them -- not both.

The Food and Drug Administration (FDA) may issue a revision of its warning on Pfizer's controversial smoking-cessation drug Chantix.

Children and adolescents who abuse alcohol or are sexually active are more likely to take methamphetamines (MA), also known as 'meth' or 'speed'. Research published in the open access journal BMC Pediatrics reveals the risk factors associated with MA use, in both low-risk children (those who don't take drugs) and high-risk children (those who have taken other drugs or who have ever attended juvenile detention centres). MA is a stimulant, usually smoked, snorted or injected.